feed,title,long_url,short_url
Benzinga,Polaryx Therapeutics Receives Both Rare Pediatric Disease and Orphan Drug Designations for the Treatment of Krabbe Disease With PLX-300,https://www.benzinga.com/pressreleases/21/02/n19605607/polaryx-therapeutics-receives-both-rare-pediatric-disease-and-orphan-drug-designations-for-the-tre,https://j.mp/2OmmA8N
Benzinga,Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules,https://www.benzinga.com/pressreleases/21/02/g19605606/cancer-genetics-announces-17-5-million-common-stock-offering-priced-at-the-market-under-nasdaq-rul,https://j.mp/3aVt2eM
Benzinga,DRI Healthcare Trust Announces Pricing of Initial Public Offering of Trust Units,https://www.benzinga.com/pressreleases/21/02/n19605590/dri-healthcare-trust-announces-pricing-of-initial-public-offering-of-trust-units,https://j.mp/2MREgsw
